GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Titan Pharmaceuticals
Titan Pharmaceuticals develops implants for sustained drug delivery. Its stock price reflects the long and complex history of clinical trials and commercialization of its products, particularly for the treatment of opioid addiction.
Share prices of companies in the market segment - Narco farm
Titan Pharmaceuticals is developing long-acting medications based on its ProNeura technology for the treatment of chronic conditions such as opioid addiction. We've classified it as a "Narco-Pharma" company. The chart below shows how the market is evaluating implantable drug technologies.
Broad Market Index - GURU.Markets
Titan Pharmaceuticals is a pharmaceutical company developing implantable medications for the long-term treatment of chronic conditions such as opioid addiction. It is a component of the GURU.Markets index. The chart below shows the market. See how this stock compares to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
TTNP - Daily change in the company's share price Titan Pharmaceuticals
Titan Pharmaceuticals Inc.'s daily price change reflects the high volatility inherent in biotech companies. This metric measures its sensitivity to news about the development of its long-term drug delivery systems.
Daily change in the price of a set of shares in a market segment - Narco farm
Titan Pharmaceuticals develops implants for long-term drug delivery, particularly for addiction treatment. This is a highly specialized and risky niche in the pharmaceutical industry. The chart below shows the volatility in this sector, reflecting the high stakes associated with new drug development.
Daily change in the price of a broad market stock, index - GURU.Markets
Titan Pharmaceuticals develops implants for long-term drug delivery. This innovative biotech company's shares react to research data and regulatory decisions. Its history exemplifies the medtech sector's contribution to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Titan Pharmaceuticals
For Titan Pharmaceuticals, year-over-year performance is the story of its ProNeura subdermal implant technology. Its market capitalization over the next 12 months depends on the success of commercializing its implant for treating opioid addiction and on progress in developing other products, which are key to its long-term survival.
Annual dynamics of market capitalization of the market segment - Narco farm
Titan Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development of long-acting medications, primarily for the treatment of addictions. Its stock price is highly volatile, reflecting investor confidence in its breakthrough potential and ability to commercialize its unique technology.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Titan Pharmaceuticals develops implantable drugs for long-term drug delivery, such as for the treatment of opioid addiction. Its year-over-year market capitalization reflects both the potential of its unique technology and the challenges of commercialization and competition from traditional drug formulations.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Titan Pharmaceuticals
Titan Pharmaceuticals develops long-acting implant-based therapies. Its monthly performance is entirely dependent on progress in its clinical programs and partnerships. Trial results are the primary driver of its value.
Monthly dynamics of market capitalization of the market segment - Narco farm
Titan Pharmaceuticals is developing Probuphine, a subcutaneous implant for the sustained delivery of buprenorphine for the treatment of opioid addiction. The company's success depends on the commercialization of this product. The chart of the pharmaceutical addiction sector reflects the social significance and complexities of this market, where Titan offers its unique solution.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Titan Pharmaceuticals is developing an implant for long-term drug delivery, specifically for the treatment of opioid addiction. This medical technology has great potential. The company's stock price is not dependent on the market, but rather is determined by the results of clinical trials and the commercial success of its product.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Titan Pharmaceuticals
Titan Pharmaceuticals develops implants for long-term drug delivery, particularly for the treatment of opioid addiction. Its weekly stock price performance reflects the commercial success of its Probuphine product, as well as news of the development of new implants for other conditions.
Weekly dynamics of market capitalization of the market segment - Narco farm
Titan Pharmaceuticals develops implants for long-term drug delivery, for example, to treat opioid addiction. Its success depends on one key product and partnerships. This chart allows us to separate the impact of specific company news from general trends in the pharmaceutical industry.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Titan Pharmaceuticals develops implants for long-term drug delivery. The company's fate depends on the success of a single product. This chart shows how company news (such as trial data) impacts its performance, completely separate from overall stock market trends.
Market capitalization of the company, segment and market as a whole
TTNP - Market capitalization of the company Titan Pharmaceuticals
Titan Pharmaceuticals' market capitalization reflects investor valuation of its ProNeura subdermal implant technology. The chart shows how the market values its core product—an implant for treating opioid addiction. Its low valuation reflects the product's commercial failures and the company's ongoing search for new applications for its technology.
TTNP - Share of the company's market capitalization Titan Pharmaceuticals within the market segment - Narco farm
Titan Pharmaceuticals develops implantable systems for long-term drug delivery. Its market share in the pharmaceutical sector is small, but it is a leader in its niche. Its market capitalization is based on its ProNeura technology, which is used to treat opioid addiction and can be applied to other chronic conditions.
Market capitalization of the market segment - Narco farm
This chart shows the total market capitalization of the entire legal cannabis and pharmaceutical sectors. For Titan Pharmaceuticals, with its long-term drug delivery technology, this line is a roadmap for the fight against addiction. Its dynamics demonstrate the willingness of investors to invest in new approaches to treating chronic conditions that require ongoing therapy.
Market capitalization of all companies included in a broad market index - GURU.Markets
Titan Pharmaceuticals develops implants for long-term drug delivery, particularly for addiction treatment. Its market capitalization is determined by the valuation of its technology. This market share is determined by the search for more convenient and effective treatments for chronic conditions.
Book value capitalization of the company, segment and market as a whole
TTNP - Book value capitalization of the company Titan Pharmaceuticals
Titan Pharmaceuticals develops implants for long-term drug delivery, for example, for addiction treatment. Its book value is a combination of its intellectual property (ProNeura technology) and financial resources. This is its capital for R&D and partnerships. How has this changed? The chart below shows.
TTNP - Share of the company's book capitalization Titan Pharmaceuticals within the market segment - Narco farm
Titan Pharmaceuticals develops implants for sustained drug delivery. Its ProNeura technology requires the manufacturing infrastructure to create these complex devices. The chart shows the company's share of the physical infrastructure required to produce next-generation drug delivery systems.
Market segment balance sheet capitalization - Narco farm
Titan Pharmaceuticals is a biopharmaceutical company. Pharmaceuticals, as the chart shows, are knowledge- and capital-intensive. Titan focuses on developing drug delivery systems, and its capital is its intellectual property and R&D infrastructure.
Book value of all companies included in the broad market index - GURU.Markets
Titan Pharmaceuticals' assets are not its manufacturing plants, but rather its ProNeura technology for subcutaneous implantation of long-acting medications, specifically for the treatment of opioid addiction. The book value reflects the intellectual property and capital for developing this drug delivery platform.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Titan Pharmaceuticals
Titan Pharmaceuticals develops implants for long-term drug delivery. Its market capitalization is based on its ProNeura technology and its potential to treat chronic diseases such as opioid addiction.
Market to book capitalization ratio in a market segment - Narco farm
Titan Pharmaceuticals develops implants for long-term drug delivery, particularly for addiction treatment. The chart shows how investors view its unique technology and its commercial prospects in the challenging pharmaceutical market.
Market to book capitalization ratio for the market as a whole
Titan Pharmaceuticals develops implants for long-term drug delivery, for example, for addiction treatment. The company's key asset is its ProNeura technology. This chart shows the premium the market is willing to pay for unique medical technologies, even if their commercialization is slow.
Debts of the company, segment and market as a whole
TTNP - Company debts Titan Pharmaceuticals
Titan Pharmaceuticals develops implantable systems for long-term drug delivery. As a commercialization-stage company, it uses capital to support manufacturing and marketing. This chart illustrates the financial challenges associated with bringing an innovative but niche medical technology to market.
Market segment debts - Narco farm
Titan Pharmaceuticals is developing long-acting medications based on its ProNeura implant technology. Its lead product is designed for maintenance treatment of opioid addiction. The chart shows how the company is funding the commercialization of its niche product and the development of new applications for its unique drug delivery platform.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Titan Pharmaceuticals
Titan Pharmaceuticals develops implantable systems for long-term drug delivery, particularly for the treatment of opioid addiction. The development and clinical trials of such medical devices are lengthy and expensive. This chart illustrates the company's reliance on debt to finance its high-risk R&D programs.
Market segment debt to market segment book capitalization - Narco farm
Titan Pharmaceuticals develops implantable systems for long-term drug delivery, particularly for the treatment of opioid addiction. This chart shows how a small pharmaceutical company finances its research and development. It compares its debt load to the market capitalization of the pharmaceutical sector as a whole, reflecting its financial risks.
Debt to book value of all companies in the market
Titan Pharmaceuticals develops implantable drugs for the long-term treatment of chronic diseases, such as opioid addiction. Pharmaceutical development requires significant investment. How heavily does the company rely on debt? This chart of total market debt helps assess its financial strategy and risks.
P/E of the company, segment and market as a whole
P/E - Titan Pharmaceuticals
Titan Pharmaceuticals develops implantable devices for long-term drug delivery, particularly for the treatment of opioid addiction. This chart shows how investors value its ProNeura technology. The valuation depends on the commercial success of its products and partnerships.
P/E of the market segment - Narco farm
Titan Pharmaceuticals is a pharmaceutical company specializing in the development of products for sustained drug delivery using its ProNeura technology, particularly for the treatment of chronic diseases. This chart illustrates the average rating in the pharmaceutical sector, which values innovative delivery technologies that can improve patient adherence.
P/E of the market as a whole
Titan Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing long-acting therapies for chronic diseases using its ProNeura technology. This chart reflects the overall risk appetite of investors in biotech. It helps us understand whether TTNP's valuation is based on faith in its unique drug delivery platform or whether it moves in line with overall sector sentiment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Titan Pharmaceuticals
Titan Pharmaceuticals is developing a drug based on ProNeura technology—a subcutaneous implant for sustained drug delivery, specifically for the treatment of opioid addiction. This chart shows how the market assesses the commercial potential of this unique technology and its ability to carve out a niche in the addiction treatment market.
%20P%2FE%20Titan%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Titan-Pharmaceuticals&v=1772627284041 "Chart of the company's future (projected) P/E Titan Pharmaceuticals")
Future (projected) P/E of the market segment - Narco farm
Titan Pharmaceuticals develops implants for long-term drug delivery, specifically for the treatment of opioid addiction. The chart reflects future revenue forecasts for the sector. It helps understand the market's confidence in ProNeura's technology and its ability to offer a more convenient and effective treatment for chronic diseases.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Narco-farm&v=1772627284069 "Future (projected) P/E graph of the market segment - Narco farm")
Future (projected) P/E of the market as a whole
Titan Pharmaceuticals develops implants for sustained drug delivery, specifically for the treatment of opioid addiction. It is a technology platform for improving therapy. This healthcare risk appetite chart reflects investors' willingness to invest in innovative drug delivery systems.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772627284098 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Titan Pharmaceuticals
Titan Pharmaceuticals develops implants for long-term, continuous drug delivery, particularly for the treatment of opioid addiction. Profits depend on the commercial success of its ProNeura technology. This chart shows the financial results of the company, which is focused on an innovative drug therapy method.
Profit of companies in the market segment - Narco farm
Titan Pharmaceuticals is developing an implant for long-term, continuous drug delivery to treat chronic conditions, particularly opioid addiction. This chart shows overall profitability in the addiction treatment sector, where innovative drug delivery methods that ensure stable concentrations and compliance are in high demand.
Overall market profit
Titan Pharmaceuticals develops implantable medications for the long-term treatment of chronic conditions, such as opioid addiction. The need for such treatments is enormous and unaffected by economic conditions. The company's success is determined by clinical trial results and regulatory approvals, not by the macroeconomic trends visible in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Titan Pharmaceuticals
Titan Pharmaceuticals develops implantable medications for the long-term treatment of chronic diseases, particularly opioid addiction. Future profits depend on the commercial success of its ProNeura technology. This chart reflects analyst expectations regarding the potential of sustained-release implants.
%20profit%20of%20the%20company%20Titan%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Titan-Pharmaceuticals&v=1772627284185 "Graph of future (projected) profit of the company Titan Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Narco farm
Titan Pharmaceuticals develops implantable medications for the long-term treatment of chronic conditions such as opioid addiction. Its ProNeura technology provides sustained drug release over several months. This graph shows revenue projections for the pharmaceutical sector, helping to assess the potential of Titan's innovative delivery system.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Narco-farm&v=1772627284204 "Graph of future (predicted) profits of companies in a market segment - Narco farm")
Future (predicted) profit of the market as a whole
Titan Pharmaceuticals develops implants for long-term drug delivery, for example, for addiction treatment. Its success depends on commercialization and partnerships. This economic outlook affects the overall solvency of the healthcare system, which underpins the implementation of innovative treatments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772627284216 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Titan Pharmaceuticals
Titan Pharmaceuticals develops implants for long-term drug delivery, specifically for the treatment of opioid addiction. Its revenue depends on the success of its product, Probuphine. This chart shows how investors assess its market potential in combating the opioid crisis.
P/S market segment - Narco farm
Titan Pharmaceuticals specializes in developing long-acting drugs based on its ProNeura subcutaneous implant technology. This platform maintains stable drug levels in the blood for several months. This chart shows the average revenue estimate for the sector, helping to understand how the market views the potential of this drug delivery technology.
P/S of the market as a whole
Titan Pharmaceuticals develops implants for long-term drug delivery, particularly for the treatment of opioid addiction. This chart highlights that the valuation of such companies is based on the potential of their unique delivery technology to transform approaches to chronic disease treatment, not on current revenue.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Titan Pharmaceuticals
Titan Pharmaceuticals develops long-acting medications based on its ProNeura implant technology. Its primary focus is the treatment of chronic conditions, such as opioid addiction. Estimates based on future revenue are crucial for the company. They reflect investor expectations for the commercial success of its products and the potential of its platform for delivering other medications.
%20P%2FS%20Titan%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Titan-Pharmaceuticals&v=1772627284286 "The graph of the company's future (projected) P/S Titan Pharmaceuticals")
Future (projected) P/S of the market segment - Narco farm
Titan Pharmaceuticals is developing long-acting medications based on its implantable ProNeura technology, specifically for the treatment of chronic conditions such as opioid addiction. This chart shows how investors view the company's future revenues relative to the pharmaceutical sector. It demonstrates the market's confidence in the potential of its drug delivery platform.
%20P%2FS%20market%20segment%20graph%20-%20Narco%20farm&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Narco-farm&v=1772627284321 "Future (projected) P/S market segment graph - Narco farm")
Future (projected) P/S of the market as a whole
Titan Pharmaceuticals is developing implants for long-term drug delivery, specifically for the treatment of opioid addiction. The company's success depends on the commercialization of its ProNeura platform. This graph of investor expectations reflects the hope for new technologies in the treatment of addictions and chronic diseases.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772627284329 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Titan Pharmaceuticals
This chart shows Titan Pharmaceuticals' revenue, generated through royalties and license fees related to its ProNeura technology for long-term drug delivery used in the treatment of opioid addiction. Its growth is dependent on the success of its commercialization partners.
Sales of companies in the market segment - Narco farm
Titan Pharmaceuticals develops long-acting drugs for the treatment of chronic diseases using its ProNeura technology. Its revenue may consist of royalties from previously approved products and payments from partners. Future revenue depends on the success of its new developments, such as those for the treatment of Parkinson's disease.
Overall market sales
Titan Pharmaceuticals develops long-acting medications for the treatment of chronic diseases using its subcutaneous implant technology. The company focuses on treating opioid addiction. This overall economic outlook doesn't diminish the urgent need for more effective addiction treatments, which is Titan's primary driver.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Titan Pharmaceuticals
Titan Pharmaceuticals is developing long-acting medications based on its ProNeura subcutaneous implant technology, primarily for the treatment of chronic conditions such as opioid addiction. Future revenues are dependent on the success of its developments. This chart reflects analyst expectations for the commercial potential of its drug delivery platform.
%20sales%20of%20the%20company%20Titan%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Titan-Pharmaceuticals&v=1772627284501 "Schedule of future (projected) sales of the company Titan Pharmaceuticals")
Future (projected) sales of companies in the market segment - Narco farm
Titan Pharmaceuticals is developing subcutaneous implants for sustained drug delivery, particularly for addiction treatment. This chart shows the outlook for the pharmaceutical market. Is demand for technologies that provide sustained drug release and patient convenience growing? This reflects a general trend.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Narco-farm&v=1772627284574 "Schedule of future (projected) sales of companies in the market segment - Narco farm")
Future (projected) sales of the market as a whole
Titan Pharmaceuticals is developing long-acting implantable medications, particularly for addiction treatment. Demand for such treatments is driven by medical needs and healthcare systems, not economic cycles. This timeline is of minimal importance, as combating addiction is a public health priority.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772627284584 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Titan Pharmaceuticals
Titan Pharmaceuticals is developing long-acting medications based on its implantable ProNeura technology, specifically for the treatment of chronic conditions such as opioid addiction. This chart shows its financial trajectory. Profitability depends on the successful commercialization of this platform and partnerships with other pharmaceutical companies for its use.
Market segment marginality - Narco farm
Titan Pharmaceuticals, Inc. specializes in developing implantable systems for long-term drug delivery, particularly for the treatment of chronic conditions such as opioid addiction. This chart depicts the company's financial position, whose profitability depends on the commercial success of its unique technology platform.
Market marginality as a whole
Titan Pharmaceuticals develops extended-release medications, particularly for the treatment of opioid addiction. The company strives to improve patient compliance. This overall profitability chart reflects the state of the economy, which impacts funding for addiction treatment programs and the healthcare system's readiness to embrace new technologies.
Employees in the company, segment and market as a whole
Number of employees in the company Titan Pharmaceuticals
Titan Pharmaceuticals develops implants for sustained drug delivery, particularly for the treatment of opioid addiction. Its small team manages manufacturing and partnerships. This chart shows how the company is focusing its resources on commercializing its core product, Probuphine, and exploring new applications for its technology.
Share of the company's employees Titan Pharmaceuticals within the market segment - Narco farm
Titan Pharmaceuticals develops implantable medications for the long-term treatment of chronic conditions, such as opioid addiction. The development and production of such complex drug delivery systems requires teams of engineers and pharmacists. This chart shows the company's market share, reflecting its unique technological expertise and R&D potential.
Number of employees in the market segment - Narco farm
Titan Pharmaceuticals develops drugs for the long-term treatment of chronic diseases using subcutaneous implants. Its key product, Probuphine, is designed to treat opioid addiction. The chart shows employment in the addiction pharmaceuticals sector. The implant technology provides sustained drug release over several months.
Number of employees in the market as a whole
Titan Pharmaceuticals develops long-term drug delivery systems, particularly for addiction treatment. Its growth depends on success in clinical trials and partnerships. This chart shows general trends, but Titan is a niche biopharmaceutical company, where employment is driven by progress in developing specific medical solutions.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Titan Pharmaceuticals (TTNP)
Titan Pharmaceuticals specializes in sustained drug delivery technologies, specifically the ProNeura implant (for example, for the treatment of opioid addiction). This chart shows how the market values their IP. It reflects the market value per employee, which is a measure of the value of their unique drug delivery platform.
%20of%20the%20company%20Titan%20Pharmaceuticals%20(TTNP)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Titan-Pharmaceuticals-TTNP&v=1772627284768 "Chart of market capitalization per employee (in thousands of dollars) of the company Titan Pharmaceuticals (TTNP)")
Market capitalization per employee (in thousands of dollars) in the market segment - Narco farm
Titan Pharmaceuticals (TTNP) develops implantable medications for the long-term treatment of chronic conditions, such as opioid addiction. In the pharmaceutical industry, this metric reflects the value of the delivery technology. The high employee rating may be due to the fact that their ProNeura platform provides stable drug release over several months, solving the problem of medication adherence.
%20by%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Narco-farm&v=1772627284837 "Market capitalization per employee (in thousands of dollars) by market segment - Narco farm")
Market capitalization per employee (in thousands of dollars) for the overall market
Titan Pharmaceuticals develops extended-release medications, particularly for addiction treatment. Its pricing is based on ProNeura technology. The chart shows a high cost per employee, as this platform can ensure stable drug delivery over several months, a significant benefit for patients.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772627284905 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Titan Pharmaceuticals (TTNP)
Titan Pharmaceuticals is a biotech company specializing in long-term drug delivery technology (implants), specifically for the treatment of opioid addiction. This chart shows the company's success in commercializing its technology (Probuphine). Earnings per employee (EP) here represents royalty income and sales revenue.
%20Chart%20Titan%20Pharmaceuticals%20(TTNP)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Titan-Pharmaceuticals-TTNP&v=1772627284939 "Company Profit Per Employee (in thousands of dollars) Chart Titan Pharmaceuticals (TTNP)")
Profit per employee (in thousands of dollars) in the market segment - Narco farm
Titan Pharmaceuticals, Inc. develops implantable medications for the long-term treatment of chronic conditions, such as opioid addiction. In this pharmaceutical niche, the efficiency per employee depends on the success of their unique drug delivery technology. The graph shows the financial return per team, which is an indicator of the commercial potential of their ProNeura platform.
%20in%20the%20market%20segment%20-%20Narco%20farm&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Narco-farm&v=1772627284953 "Chart of profit per employee (in thousands of dollars) in the market segment - Narco farm")
Profit per employee (in thousands of dollars) for the market as a whole
Titan Pharmaceuticals is a biotech company specializing in long-term drug delivery implants (ProNeura technology), for example, for the treatment of opioid addiction. It's an R&D company. This chart, showing average market profitability, demonstrates how the biotech model, with its small workforce and high stakes, differs from the rest of the economy.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772627284987 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Titan Pharmaceuticals (TTNP)
Titan Pharmaceuticals develops sustained-release medications, for example, for addiction treatment. At the commercialization stage, this graph demonstrates the market success of their ProNeura technology. Increasing revenue per employee will indicate demand for their implants, monetizing their unique drug delivery system.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Titan-Pharmaceuticals-TTNP&v=1772627285025 "Sales chart per company employee Titan Pharmaceuticals (TTNP)")
Sales per employee in the market segment - Narco farm
Titan Pharmaceuticals (TTNP) is a biotech focused on developing sustained drug delivery systems (for example, the Probuphine implant for the treatment of opioid addiction). This chart shows the average output in the sector. For TTNP, this is an indicator of how productive their R&D and commercial teams (if they have sales) are.
Sales per employee for the market as a whole
Titan Pharmaceuticals (TTNP) specializes in developing implants for long-term drug delivery (for example, for the treatment of opioid addiction). Their business model is R&D and licensing. This chart reflects their R&D status: revenue, if any, comes from partnerships rather than mass sales.
Short shares by company, segment and market as a whole
Shares shorted by company Titan Pharmaceuticals (TTNP)
Titan Pharma (TTNP) specializes in implants for long-term drug delivery, such as for the treatment of opioid addiction. This chart tracks short positions. The short positions may be related to the company's long history of commercial failures and skepticism about the acceptance of its technology by doctors.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Titan-Pharmaceuticals-TTNP&v=1772627285132 "Short Shares Chart for the Company Titan Pharmaceuticals (TTNP)")
Shares shorted by market segment - Narco farm
Titan Pharmaceuticals (TTNP) specializes in developing implantable drug delivery systems (ProNeura), specifically for the treatment of opioid addiction. This chart aggregates short positions across the biotech sector. It reflects investor skepticism regarding the commercial success of niche drug delivery systems.
Shares shorted by the overall market
Titan Pharmaceuticals develops long-term drug delivery systems (for example, for the treatment of opioid addiction). This chart reflects the overall market pessimism. This is a biotech company with a history of R&D failures. When investors are fearful, they don't give "second chances" to companies that have already burned them in the past.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Titan Pharmaceuticals (TTNP)
Titan Pharmaceuticals uses implants (ProNeura) for long-term drug delivery, for example, to treat opioid addiction. This graph represents the commercialization "pulse." The "temperature" was "overheated" in anticipation of sales, but "cooled" due to difficulties in bringing the product to market.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Titan-Pharmaceuticals-TTNP&v=1772627285190 "RSI 14 indicator chart for the company's stock Titan Pharmaceuticals (TTNP)")
RSI 14 Market Segment - Narco farm
Titan Pharma (TTNP) is a biotech company specializing in implants (ProNeura) for long-term, continuous drug delivery, such as for addiction treatment. This chart tracks overall sentiment in the Pharma/Cannabis sector. It helps investors understand whether TTNP's performance reflects their platform or whether the entire biotech sector is overheated or oversold.
RSI 14 for the overall market
For Titan Pharma (TTNP), a biotech company, this chart is a lifeline showing capital availability. During periods of market euphoria, investors are willing to generously fund risky but promising R&D projects. During periods of panic, the cash spigot is turned off, and companies burning through cash risk running out of funds.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TTNP (Titan Pharmaceuticals)
Titan Pharmaceuticals is the developer of ProNeura, a subcutaneous implant technology for long-term (6-12 months) drug delivery, for example, for the treatment of opioid addiction. This chart shows the speculative average price target from analysts, based on their belief in the commercial potential of this R&D platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TTNP-Titan-Pharmaceuticals&v=1772627285224 "A chart showing analyst consensus forecasts for the expected stock price. TTNP (Titan Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price TTNP (Titan Pharmaceuticals)
Titan Pharma is a biotech company that developed the ProNeura platform, a long-term drug delivery implant. Its flagship product (Probuphine) treats opioid addiction. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the stock price and the target, reflecting their view on this technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TTNP-Titan-Pharmaceuticals&v=1772627285244 "A chart showing the difference between the consensus forecast and the actual stock price. TTNP (Titan Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Narco farm
Titan Pharma (TTNP) is a biotech company specializing in long-term drug delivery implants (ProNeura technology), particularly for the treatment of opioid addiction. This chart shows general expectations for the pharmaceutical sector, reflecting experts' confidence in this delivery technology.
Analysts' consensus forecast for the overall market share price
Titan Pharmaceuticals is a biotech company specializing in the development of implants (ProNeura) for sustained drug delivery, specifically for the treatment of opioid addiction. This chart reflects the overall market "risk appetite." For Titan, a clinical-stage company, overall market optimism (risk appetite) is critical for attracting capital for R&D.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Titan Pharmaceuticals
Titan Pharmaceuticals (TTNP) is an R&D veteran. Their signature technology is their delivery technology (ProNeura): a tiny implant (like a match) that slowly (6-12 months) releases a drug (for example, to treat opioid addiction). This chart is a summary indicator of their battle for survival. It reflects their (meager) royalties and their (desperate) struggle to keep the money going.
AKIMA Market Segment Index - Narco farm
Titan Pharmaceuticals (TTNP) specializes in long-term drug delivery. Their key technology is ProNeura, a tiny subcutaneous implant that continuously releases a drug (such as buprenorphine for opioid addiction) for six months. This chart shows the average index for the segment. It helps assess how this implant technology compares to the average.
The AKIM Index for the overall market
Titan Pharmaceuticals is a pharmaceutical company developing implants for long-term drug delivery (for addiction and itching treatment). This chart, which reflects the market average, provides a macro backdrop. It helps assess how TTNP, which is struggling to commercialize its ProNeura technology, stacks up against overall trends.
